StemGenex Supports Rheumatoid Arthritis Awareness Day
February 2, 2017LA JOLLA, Calif. – Feb. 2, 2017 – Today marks the annual Rheumatoid Arthritis Awareness Day, which was created to improve the nation’s understanding of Rheumatoid Arthritis (“RA”) so that … Read More
StemGenex Comments on FDA Docket to Support Stem Cell Therapy
November 29, 2016LA JOLLA – November 29, 2016 – StemGenex recently submitted comments to the Food and Drug Administration (FDA) docket on the future regulation of adult adipose-derived stem cell treatments, “Draft … Read More
Stem cell therapy helps local stroke, MS patients
October 27, 2016Stem cells for MS are offering hope to many with debilitating conditions, including to Calumet residents who hope to benefit from new therapies using their own cells. Mike Bausano suffered … Read More
Stem Cell Treatment Shows Benefits for Multiple Sclerosis - Karin Shares her Story Choosing StemGenex Medical Group
October 4, 2016“After being on the phone for hours and having all my questions answered by StemGenex about stem cell treatment for Multiple Sclerosis, I booked an appointment. I had stem cell … Read More
Stem Cell Patients Passionately Champion Life-Changing Treatments at FDA Hearing
October 4, 2016Nearly 100 individuals traveled from all over the United States to Washington, D.C. to speak face-to-face with the Food and Drug Administration (FDA) about the future regulation of stem cell … Read More
MS Patients Needed for Stem Cell Clinical Study Participation
October 3, 2016Among the different therapeutic approaches being explored for treating MS, adult stem cell therapy continues to be one of the most discussed and anticipated in the MS community. “Stem cells” — the common term … Read More
Stem Cell Treatment Shows Quality of Life Benefits for Parkinson’s: Newt Shares his Story about Choosing StemGenex
September 28, 2016“My name is Newt and approximately 20 years ago, I asked my doctor about the shaking in my right hand. He said he didn’t want to alarm me, but this … Read More
Support Stem Cell Therapy: Last Chance to Comment on FDA Docket
September 27, 2016The FDA is currently in the process of finalizing a regulatory pathway for stem cell therapies. With less than one day before the FDA docket closes, we urge you to share … Read More
StemGenex Presents at FDA Hearing in Washington, D.C.
September 20, 2016LA JOLLA – September 20, 2016 – “Stem cells have arrived and have captivated the scientific and medical communities. With this excitement comes responsibility and with this responsibility comes regulation,” … Read More
StemGenex Announces Steven A. Brody, M.D., Ph.D. Chief Scientific Officer
September 8, 2016LA JOLLA – September 8, 2016 – StemGenex, a world leader offering access to autologous adipose-derived stem cell treatment, recently announced it has named Steven A. Brody, M.D., Ph.D. as … Read More
